- Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?J Bines
Department of Medical Oncology, Instituto Nacional de Cancer, Rio de Janeiro, Brazil
Ann Oncol 25:1079-85. 2014..Based on preclinical observations, there is limited rationale to administer the taxane before the anthracycline...
- Effective but cost-prohibitive drugs in breast cancer treatment: a clinician's perspectiveJose Bines
Instituto Nacional de Cancer, Rio de Janeiro, Brazil
Cancer 113:2353-8. 2008..Practical treatment choices need to be made based on the best available cost-effective information. This article reviews new and emerging medical strategies that may improve the cost-effectiveness equation...